Latest Breaking News On - Portage biotech - Page 2 : comparemela.com

Short Interest in Portage Biotech Inc. (NASDAQ:PRTG) Decreases By 57.8%

Portage Biotech Inc. (NASDAQ:PRTG – Get Free Report) was the recipient of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 6,500 shares, a decrease of 57.8% from the March 15th total of 15,400 shares. Based on an average daily trading volume, of 59,500 […]

Citadel-advisors
Goldman-sachs-group-inc
Nasdaq
Portage-biotech-inc
Millennium-management
Renaissance-technologies
Blackrock-inc
Portage-biotech-company-profile
Portage-biotech
Get-free-report
Goldman-sachs-group

Portage Biotech Inc.: Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives

Portage Biotech Inc.: Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Dennis-riedl
Company-annual-report-on-form
Exchange-commission
Linkedin-at-portage-biotech-inc
Portage-biotech-inc
Nasdaq
Portage-biotech
Annual-report

Portage Biotech (PRTG) to Expand Evaluation of Strategic Alternatives

Portage Biotech (PRTG) to Expand Evaluation of Strategic Alternatives
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nasdaq
Portage-biotech-inc
Portage-biotech

Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives

Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Nasdaq
Company-annual-report-on-form
Exchange-commission
Portage-biotech-inc
Linkedin
Biotech-announces-plans
Portage-biotech
Annual-report

Baystreet.ca - Portage Down on Announcing Alternatives

Portage Biotech Inc. (NASDAQ: PRTG) shares stumbled Friday, as the Westport, Conn.-based company a clinical-stage immuno-oncology concern advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported that it is expanding .

Westport
Newfoundland
Canada
Portage-biotech-inc
Nasdaq
Portage-biotech